Suchergebnisse - "Cappello, Maria"

PubPharm (12)

1

Switching from VEDOlizumab intravenous to subcutaneous formulation in ulcerative colitis patients in clinical remission : The SVEDO Study, an IG-IBD study

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2024

von Ribaldone, D. | Parisio, L. | Variola, A. | +39

2

The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2023

von Macaluso, F. | Grova, M. | Saladino, M. | +11

3

Real-life experience of infliximab biosimilar in pediatric-onset inflammatory bowel disease : data from the Sicilian Network for Inflammatory Bowel Disease

enthalten in: European journal of gastroenterology & hepatology | 2022

von Dipasquale, V. | Pellegrino, S. | Ventimiglia, M. | +9

4

Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease : the IG-IBD LIVE study

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Pugliese, D. | Privitera, G. | Crispino, F. | +58

CommentIn: Aliment Pharmacol Ther. 2022 Aug;56(4):731-732. - PMID 35879894

5

Two-year effectiveness and safety of golimumab in ulcerative colitis : An IG-IBD study

enthalten in: United European gastroenterology journal | 2021

von Pugliese, D. | Privitera, G. | Rogai, F. | +29

6

The SPOSIB SB2 Sicilian Cohort : Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches

enthalten in: Inflammatory bowel diseases | 2021

von Macaluso, F. | Fries, W. | Viola, A. | +19

7

A propensity score weighted comparison of Vedolizumab, Adalimumab, and Golimumab in patients with ulcerative colitis

enthalten in: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver | 2020

von Macaluso, F. | Ventimiglia, M. | Fries, W. | +20

8

The PROSIT Cohort of Infliximab Biosimilar in IBD : A Prolonged Follow-up on the Effectiveness and Safety Across Italy

enthalten in: Inflammatory bowel diseases | 2019

von Armuzzi, A. | Fiorino, G. | Variola, A. | +30

9

A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn's Disease : Real-Life Data From the Sicilian Network for Inflammatory Bowel Disease

enthalten in: Journal of Crohn's & colitis | 2019

von Macaluso, F. | Fries, W. | Privitera, A. | +26

10

Stevens-Johnson syndrome on treatment with sulfasalazine for Crohn's disease : Need for a multidisciplinary approach

enthalten in: The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology | 2019

von Viola, A. | Caltagirone, A. | Campisi, G. | +2